Tech Company Financing Transactions

Rodin Therapeutics Funding Round

Atlas Venture, Johnson & Johnson Development Corporation and private investors participated in a $12.9 million Series A funding round for Rodin Therapeutics. This venture round was recorded on 5/29/2014.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

300 Technology Sq. 8th Floor
Cambridge, MA 02139
USA

Phone

(857) 201-2770

Website

www.rodintherapeutics.com

Email Address

Not Recorded

Overview

Rodin is harnessing the power of epigenetic regulation of neuronal function to treat diseases of the brain. We believe modulation of selective epigenetic regulatory processes can restore synaptic plasticity and cognitive function in degenerative brain diseases, as well as to aid the brain in reducing negative associations with traumatic memories.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Bruce Booth

        

Chairman

Martin Jefson

        

Chief Executive Officer

Adam Rosenberg

        

Chief Medical Officer

Michael Ryan

        

Vice President

Magnus Ivarsson

        

VP - Bus. Development

Anne Sullivan

        

VP - Operations

Steven Sweeney

        

VP - R & D

Berkley Lynch

        

Browse more venture capital transactions:

Prev: 5/29/2014: Fundrise venture capital transaction
Next: 5/29/2014: SteelBrick venture capital transaction

Share this article

About Our Venture Capital Transactions Database

Our team works diligently to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary